Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorBayramoglu, Gulcin
dc.contributor.authorOzgumus, Osman Birol
dc.contributor.authorKolayli, Fetiye
dc.contributor.authorKamburoglu, Ahu
dc.contributor.authorBesli, Yesim
dc.contributor.authorDinc, Ugur
dc.contributor.authorAydin, Faruk
dc.date.accessioned2021-11-09T19:50:11Z
dc.date.available2021-11-09T19:50:11Z
dc.date.issued2014
dc.identifier.issn0374-9096
dc.identifier.urihttps://doi.org/10.5578/mb.7389
dc.identifier.urihttps://hdl.handle.net/20.500.12440/4211
dc.description.abstractAlthough Salmonella enterica serotype Paratyphi B is the less frequently isolated serotype worldwide and in Turkey, it is the most common serotype in our hospital, with a marked increase in 2007. The purpose of this study was to investigate the antibiotic susceptibility and the extended spectrum beta-lactamase (ESBL) profile, and molecular epidemiology of S. Paratyphi B isolates detected in our hospital microbiology laboratory. Seventy isolates identified as S. Paratyphi B from 109 Salmonella isolates obtained from clinical specimens from different patients between October 2005 and December 2012, were included in the study. In addition to conventional methods, isolates were identified using the Phoenix automated microbiology system (Becton Dickinson, USA). Serotyping of the isolates was performed on the basis of slide agglutination and the Kauffmann-White scheme. The antibiotic susceptibility of the isolates was determined using the BD Phoenix (TM) automated system and disk diffusion test. ESBL enzymes were investigated using the combined disk test, isoelectric focusing, polymerase chain reaction (PCR) and sequence analysis. The molecular epidemiology of the 51 isolates obtained between October 2005 and August 2008 was examined with pulsed-field gel electrophoresis (PFGE) using the Xbal enzyme. S. Paratyphi B isolates were obtained from 70 specimens (46 blood, 16 fecal, 4 bone marrow, 2 urine and 2 wound) each from different patients. Resistance to nalidixic acid was determined in 18.6%, resistance to ampicillin, cefotaxime and cefepime in 2.9% and to ceftazidime and co-trimoxazole in 1.4% of the isolates. ESBL production was detected only in two isolates; in one TEM-1 was accompanied by CTX-M-15 and in the other isolate CTX-M-3 was found. Forty-six of the 51 isolates (90%) were found to be genetically related by PFGE and were placed in cluster A. The distribution of the isolates in cluster A revealed six subtypes as A1 (n= 7), A2 (n= 11), A3 (n= 7), A4 (n= 18), AS (n= 2) and A6 (n= 1). Three different patterns not related to the cluster A were determined in the remaining five isolates (two were B, one of each was C, D and E). In conclusion, although the rate of antibiotic resistance was low in the S. Paratyphi B isolates in our hospital, rare types of ESBLs such as CTX-M-3 and CTX-M-15 were detected in Salmonellae. As far as the current literature is considered, this is the first report in Turkey of bla(CTX-M-15) in Salmonella spp. and bla(CTX-M-3) genes in S. Paratyphi B. The results may indicate a possible future threat to the treatment of Salmonella infections. Since most of the isolates were genetically related, this might suggest an epidemic in our region.en_US
dc.language.isoturen_US
dc.publisherAnkara Microbiology Socen_US
dc.relation.ispartofMikrobiyoloji Bultenien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSalmonella enterica serotype Paratyphi Ben_US
dc.subjectantibiotic resistanceen_US
dc.subjectextended-spectrum beta-lactamase (ESBL), molecular epidemiologyen_US
dc.titleMolecular Epidemiology, Antimicrobial Resistance and Characterization of Extended-Spectrum Beta-Lactamases of Salmonella enterica Serotype Paratyphi B Clinical Isolatesen_US
dc.typearticleen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.description.wospublicationidWOS:000336195500001en_US
dc.departmentGümüşhane Üniversitesien_US
dc.authoridKOLAYLI, FETIYE / 0000-0003-2474-4541
dc.authoridBESLI, YESIM / 0000-0003-4574-6036
dc.identifier.volume48en_US
dc.identifier.issue2en_US
dc.identifier.startpage191en_US
dc.identifier.doi10.5578/mb.7389
dc.identifier.endpage200en_US
dc.authorwosidAYDIN, FARUK / AAL-6973-2021
dc.authorwosidTosun, Ilknur / AAL-6524-2021
dc.authorwosidBayramoglu, Gulcin / AAR-2120-2020
dc.authorwosidBESLI, YESIM / R-3270-2017
dc.description.pubmedpublicationidPubMed: 24819257en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster